These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 17257838

  • 1. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A, Pio BA, Tegley CM, Higuchi RI, Wu M, Jones TK, Marschke KB, Negro-Vilar A, Zhi L.
    Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1523-6. PubMed ID: 17257838
    [Abstract] [Full Text] [Related]

  • 2. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A, Motamedi M, Martinborough E, Zhao S, Shen Y, West S, Chang W, Kallel A, Marschke KB, López FJ, Negro-Vilar A, Zhi L.
    Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1527-31. PubMed ID: 17267219
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
    Ng RA, Guan J, Alford VC, Lanter JC, Allan GF, Sbriscia T, Lundeen SG, Sui Z.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):955-8. PubMed ID: 17134895
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.
    Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.
    Carcinogenesis; 2008 Jun 15; 29(6):1148-56. PubMed ID: 18487223
    [Abstract] [Full Text] [Related]

  • 10. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC, Astapova I, Hollenberg AN, Balk SP.
    Cancer Res; 2007 Sep 01; 67(17):8388-95. PubMed ID: 17804755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery and biological characterization of a novel series of androgen receptor modulators.
    Zhou C, Wu G, Feng Y, Li Q, Su H, Mais DE, Zhu Y, Li N, Deng Y, Yang D, Wang MW.
    Br J Pharmacol; 2008 May 01; 154(2):440-50. PubMed ID: 18414397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K, Miyachi H, Hashimoto Y, Tanatani A.
    Bioorg Med Chem; 2005 Apr 15; 13(8):2837-46. PubMed ID: 15781394
    [Abstract] [Full Text] [Related]

  • 17. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M, Ishioka J, Hyochi N, Kihara K, Hara S, Singh P, Isaacs JT, Kageyama Y.
    Prostate; 2007 Jun 01; 67(8):799-807. PubMed ID: 17373727
    [Abstract] [Full Text] [Related]

  • 18. 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production.
    Mitchell L, Wang Z, Hu LY, Kostlan C, Carroll M, Dettling D, Du D, Pocalyko D, Wade K.
    Bioorg Med Chem Lett; 2009 Mar 01; 19(5):1310-3. PubMed ID: 19201190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.